S&P 500 Futures Drop in Pre-Market Trading; Cheniere Energy Partner and UMB Financial Take the Lead
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 29 2025
0mins
Source: Barron's
Cheniere Energy Partners Performance: Cheniere Energy Partners L.P. (CQP) saw a 9.2% increase in pre-market trading.
UMB Financial Corp Performance: UMB Financial Corp. (UMBF) experienced a 4.3% rise in pre-market trading.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like RGC with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on RGC
About RGC
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Markets Closed Thursday with Mixed Results, Driven by Royal Caribbean Group's Gains and Joby Aviation's Declines
- U.S. Stock Market Performance: Stock indexes in the U.S. ended the day mixed on Thursday.
- Index Movements: The S&P 500 increased by 0.11%, while the Dow Jones Industrial Average decreased by 0.13%, and the Nasdaq fell by 0.72%.
Continue Reading
HCA Healthcare Surges After Strong Q4 Earnings and Upgraded FY25 Guidance
- Earnings Beat: HCA Healthcare reported an adjusted EPS of $8.01 for Q4, surpassing the analyst consensus of $7.43, indicating robust profitability and strong market demand.
- Stock Surge: Following the earnings report, HCA's shares jumped 9.5% to $517.00 on Tuesday, reflecting investor confidence in the company's future growth prospects.
- Upgraded Guidance: The company raised its FY25 guidance above estimates, signaling a positive outlook for business development that may attract more investor interest.
- Positive Market Reaction: HCA's favorable news boosted overall market confidence in the healthcare sector, potentially leading to further gains in related stocks.
Continue Reading